BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1134 related articles for article (PubMed ID: 30980070)

  • 1. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
    Cho H; Abe S; Nonaka S; Suzuki H; Yoshinaga S; Okuma K; Yamamoto S; Daiko H; Kato K; Sekine S; Boku N; Saito Y
    Dis Esophagus; 2024 Apr; 37(5):. PubMed ID: 38266034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.
    Minashi K; Nihei K; Mizusawa J; Takizawa K; Yano T; Ezoe Y; Tsuchida T; Ono H; Iizuka T; Hanaoka N; Oda I; Morita Y; Tajika M; Fujiwara J; Yamamoto Y; Katada C; Hori S; Doyama H; Oyama T; Nebiki H; Amagai K; Kubota Y; Nishimura K; Kobayashi N; Suzuki T; Hirasawa K; Takeuchi T; Fukuda H; Muto M
    Gastroenterology; 2019 Aug; 157(2):382-390.e3. PubMed ID: 31014996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
    Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
    Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
    Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
    Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma.
    Koterazawa Y; Nakamura T; Oshikiri T; Kanaji S; Tanaka S; Ishida T; Yamashita K; Matsuda T; Morita Y; Suzuki S; Kakeji Y
    Surg Today; 2018 Aug; 48(8):783-789. PubMed ID: 29532261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
    Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
    Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
    J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
    Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
    Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
    Tsou YK; Lee CH; Le PH; Chen BH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
    Sgourakis G; Gockel I; Lang H
    World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic submucosal dissection versus surgery for T1b esophageal carcinoma: a single-center retrospective study.
    Zhang T; Wang H; Jin T; Wu Z; Li X; Zhang Q
    J Cancer Res Clin Oncol; 2024 May; 150(5):248. PubMed ID: 38724804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcome of Additional Esophagectomy After Endoscopic Treatment for Superficial Esophageal Cancer.
    Miyata H; Sugimura K; Kanemura T; Takeoka T; Yamamoto M; Shinno N; Hara H; Omori T; Yamamoto S; Ishihara R; Wada H; Takahashi H; Nishimura J; Matsuda C; Yasui M; Yano M
    Ann Surg Oncol; 2021 Nov; 28(12):7230-7239. PubMed ID: 33959832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Kimoto T; Nagasawa S; Watanabe S; Seri S; Asato A; Shiozaki A; Fujiwara H; Konishi H; Dohi O; Ishikawa T; Elsaleh H; Yamada K
    Radiat Oncol; 2022 Nov; 17(1):191. PubMed ID: 36401267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion.
    Ikeda A; Hoshi N; Yoshizaki T; Fujishima Y; Ishida T; Morita Y; Ejima Y; Toyonaga T; Kakechi Y; Yokosaki H; Azuma T
    Intern Med; 2015; 54(22):2803-13. PubMed ID: 26567992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment.
    Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J
    Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review.
    Kam TY; Kountouri M; Roth A; Frossard JL; Huber O; Mönig S; Zilli T
    Crit Rev Oncol Hematol; 2018 Apr; 124():61-65. PubMed ID: 29548487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endoscopic therapy in early esophageal cancer.
    Malik S; Sharma G; Sanaka MR; Thota PN
    World J Gastroenterol; 2018 Sep; 24(35):3965-3973. PubMed ID: 30254401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.